Author

Ezgi Simay Karabulut

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:multiple species· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ahmet CeylaniD· 1 shared Ali Al-HakeemiD· 1 shared Alireza HanifehnezhadiD· 1 shared Aykut ÖzkuliD· 1 shared Ayşe Gökçe ErmaniD· 1 shared Buket GüliD· 1 shared Emre KoyuncuiD· 1 shared Erkan Yilmaz· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Ahmet CeylanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection

Hatoon Baazim, Emre Koyuncu, Gürol Tuncman, Mehmet Furkan Burak, Lea Merkel, Nadine Bahour, Ezgi Simay Karabulut, Grace Yankun Lee, Alireza Hanifehnezhad, Zehra Fırat Karagöz, Katalin Földes, Ilayda Engin, Ayşe Gökçe Erman, Sıdıka Öztop, Nazlıcan Filazi, , Gökhan S. Hotamışlıgil

This study identifies FABP4 as a host target that modulates SARS-CoV-2 infection, showing that its inhibition reduces viral replication and lung damage in infected hamsters.

EMBO Molecular Medicine · Jan 22, 2025Peer-reviewedMicrobiology